Case Report

Primary Nasal Septal Squamous Cell Carcinoma

Volume: 1 Number: 1 April 1, 2018

Primary Nasal Septal Squamous Cell Carcinoma

Abstract

Nasal cavity and paranasal sinus malignancies constitute only 3% of all head and neck carcinomas. Malignancies of the nasal septum are rare and comprise 9% of sinonasal malignancies. In sinonasal carcinomas, squamous cell carcinoma is the most common type of malignant tumor. Here, a 64-year-old man with a nasal septal squamous cell carcinoma is presented in the context of literature information.

Keywords

References

  1. Dulguerov P, Jacobsen MS, Allal AS, Lehmann W, Calcaterra T. Nasal and paranasal sinus carcinoma: are we making progress? A series of 220 patients and a systematic review. Cancer 2001; 92: 3012-29.
  2. Echeverria-Zumarraga M, Kaiser C, Gavilani C. Nasal septal carcinoma: initial symptom of nasal septal perforation. J Laryngol Otol 1988; 102: 834-5.
  3. Leeman DJ, Shuler KJ, Han K, Mirani N. Dedifferentiation of primary squamous cell carcinoma arising from the nasal septum. Otolaryngol Head Neck Surg 1996; 114: 131-6.
  4. Zheng W, McLaughlin JK, Chow WH, Chien HT, Blot WJ. Risk factors for cancers of the nasal cavity and paranasal sinuses among white men in the United States. Am J Epidemiol 1993; 138: 965-72.
  5. Beatty CW, Pearson BW, Kern EB. Carcinoma of the nasal septum: experience with 85 cases. Otolaryngol Head Neck Surg 1982; 90: 90-4.
  6. Fradis M, Podoshin L, Gertner R, Sabo E. Squamous cell carcinoma of the nasal septum mucosa. Ear Nose Throat J 1993; 72: 217-21.
  7. Kızıklkaya Z, Emir H, Ceylan K, Samim E. Nazal septumun primer yassı hücreli karsinomu. Türkiye Klinikleri J Med Sci 2008; 28: 977-9.
  8. Ho YM, Coman WB. Nasal septum malignancy. ANZ J Surg 2011; 81: 533-6.

Details

Primary Language

English

Subjects

Otorhinolaryngology

Journal Section

Case Report

Publication Date

April 1, 2018

Submission Date

July 16, 2017

Acceptance Date

October 2, 2017

Published in Issue

Year 2018 Volume: 1 Number: 1

APA
Keleş, E., Eroğlu, O., Karlıdağ, T., & Türker, C. (2018). Primary Nasal Septal Squamous Cell Carcinoma. European Journal of Rhinology and Allergy, 1(1), 18-20. https://doi.org/10.5152/ejra.2018.56888
AMA
1.Keleş E, Eroğlu O, Karlıdağ T, Türker C. Primary Nasal Septal Squamous Cell Carcinoma. Eur J Rhinol Allergy. 2018;1(1):18-20. doi:10.5152/ejra.2018.56888
Chicago
Keleş, Erol, Orkun Eroğlu, Turgut Karlıdağ, and Cihan Türker. 2018. “Primary Nasal Septal Squamous Cell Carcinoma”. European Journal of Rhinology and Allergy 1 (1): 18-20. https://doi.org/10.5152/ejra.2018.56888.
EndNote
Keleş E, Eroğlu O, Karlıdağ T, Türker C (April 1, 2018) Primary Nasal Septal Squamous Cell Carcinoma. European Journal of Rhinology and Allergy 1 1 18–20.
IEEE
[1]E. Keleş, O. Eroğlu, T. Karlıdağ, and C. Türker, “Primary Nasal Septal Squamous Cell Carcinoma”, Eur J Rhinol Allergy, vol. 1, no. 1, pp. 18–20, Apr. 2018, doi: 10.5152/ejra.2018.56888.
ISNAD
Keleş, Erol - Eroğlu, Orkun - Karlıdağ, Turgut - Türker, Cihan. “Primary Nasal Septal Squamous Cell Carcinoma”. European Journal of Rhinology and Allergy 1/1 (April 1, 2018): 18-20. https://doi.org/10.5152/ejra.2018.56888.
JAMA
1.Keleş E, Eroğlu O, Karlıdağ T, Türker C. Primary Nasal Septal Squamous Cell Carcinoma. Eur J Rhinol Allergy. 2018;1:18–20.
MLA
Keleş, Erol, et al. “Primary Nasal Septal Squamous Cell Carcinoma”. European Journal of Rhinology and Allergy, vol. 1, no. 1, Apr. 2018, pp. 18-20, doi:10.5152/ejra.2018.56888.
Vancouver
1.Erol Keleş, Orkun Eroğlu, Turgut Karlıdağ, Cihan Türker. Primary Nasal Septal Squamous Cell Carcinoma. Eur J Rhinol Allergy. 2018 Apr. 1;1(1):18-20. doi:10.5152/ejra.2018.56888

You can find the current version of the Instructions to Authors at: https://www.eurjrhinol.org/en/instructions-to-authors-104

Starting on 2020, all content published in the journal is licensed under the Creative Commons Attribution-NonCommercial (CC BY-NC) 4.0 International
License which allows third parties to use the content for non-commercial purposes as long as they give credit to the original work. This license
allows for the content to be shared and adapted for non-commercial purposes, promoting the dissemination and use of the research published in
the journal.
The content published before 2020 was licensed under a traditional copyright, but the archive is still available for free access.